Kyung Nam Pharm Co Ltd (053950) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.001x

Based on the latest financial reports, Kyung Nam Pharm Co Ltd (053950) has a cash flow conversion efficiency ratio of 0.001x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩81.44 Million ≈ $55.19K USD) by net assets (₩117.50 Billion ≈ $79.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 053950 company net worth for the company's overall valuation and market capitalisation.

Kyung Nam Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Kyung Nam Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kyung Nam Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kyung Nam Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore 053950 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
SRAX Inc NASDAQ:SRAX	0.394x
CRESTVIEW EXPLORATION INC F:CE7	N/A
Tirupati Graphite plc LSE:TGR	-0.032x
Distil Plc LSE:DIS	-0.129x
Hana Microelectronics Public Company Limited F:HAA1	0.055x
Eos Energy Enterprises Inc NASDAQ:EOSEW	0.028x
Cloudcoco Group PLC LSE:CLCO	-2.129x
KRUNG THAI -FGN- BA 515 F:KTB1	0.286x

Annual Cash Flow Conversion Efficiency for Kyung Nam Pharm Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Kyung Nam Pharm Co Ltd from 2007 to 2025. View today's stock price for Kyung Nam Pharm Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩108.30 Billion ≈ $73.39 Million	₩-1.68 Billion ≈ $-1.14 Million	-0.016x	-197.34%
2024-12-31	₩115.22 Billion ≈ $78.09 Million	₩1.84 Billion ≈ $1.25 Million	0.016x	+106.72%
2023-12-31	₩89.83 Billion ≈ $60.88 Million	₩693.30 Million ≈ $469.84K	0.008x	+911.06%
2022-12-31	₩93.77 Billion ≈ $63.55 Million	₩71.58 Million ≈ $48.51K	0.001x	-98.33%
2020-12-31	₩57.36 Billion ≈ $38.87 Million	₩2.62 Billion ≈ $1.77 Million	0.046x	+143.42%
2019-12-31	₩61.19 Billion ≈ $41.47 Million	₩-6.43 Billion ≈ $-4.35 Million	-0.105x	-73.03%
2018-12-31	₩28.91 Billion ≈ $19.59 Million	₩-1.75 Billion ≈ $-1.19 Million	-0.061x	-120.88%
2016-12-31	₩16.82 Billion ≈ $11.40 Million	₩4.89 Billion ≈ $3.31 Million	0.291x	+1223.07%
2010-12-31	₩21.97 Billion ≈ $14.89 Million	₩482.65 Million ≈ $327.08K	0.022x	+119.25%
2007-12-31	₩14.85 Billion ≈ $10.06 Million	₩148.79 Million ≈ $100.84K	0.010x	--

About Kyung Nam Pharm Co Ltd

KQ:053950 Korea

Market Cap

$14.62K

₩21.58 Million KRW

Market Cap Rank

#31787 Global

#2121 in Korea

Share Price

₩2280.00

Change (1 day)

-0.65%

52-Week Range

₩1435.00 - ₩2295.00

All Time High

₩2295.00